178 related articles for article (PubMed ID: 15306207)
1. Risperidone reduces K+ currents in human atrial myocytes and prolongs repolarization in human myocardium.
Gluais P; Bastide M; Grandmougin D; Fayad G; Adamantidis M
Eur J Pharmacol; 2004 Aug; 497(2):215-22. PubMed ID: 15306207
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of risperidone in mammalian cardiac cells.
Magyar J; Bányász T; Bagi Z; Pacher P; Szentandrássy N; Fülöp L; Kecskeméti V; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):350-6. PubMed ID: 12237749
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological effects of ketamine on human atrial myocytes at therapeutically relevant concentrations.
Deng CY; Yu XY; Kuang SJ; Rao F; Yang M; Shan ZX; Qian WM; Zhou ZL; Lin QX; Wu SL; Zhang YY; Lin SG
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1465-70. PubMed ID: 18671719
[TBL] [Abstract][Full Text] [Related]
4. Risperidone prolongs cardiac action potential through reduction of K+ currents in rabbit myocytes.
Gluais P; Bastide M; Caron J; Adamantidis M
Eur J Pharmacol; 2002 May; 444(3):123-32. PubMed ID: 12063072
[TBL] [Abstract][Full Text] [Related]
5. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.
Fedida D; Eldstrom J; Hesketh JC; Lamorgese M; Castel L; Steele DF; Van Wagoner DR
Circ Res; 2003 Oct; 93(8):744-51. PubMed ID: 14500335
[TBL] [Abstract][Full Text] [Related]
6. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide.
Hanada E; Ohtani H; Hirota M; Uemura N; Nakaya H; Kotaki H; Sato H; Yamada Y; Iga T
J Pharm Pharmacol; 2003 Jul; 55(7):995-1002. PubMed ID: 12906757
[TBL] [Abstract][Full Text] [Related]
8. Allitridi inhibits transient outward potassium currents in human atrial myocytes.
Deng CY; Rao F; Kuang SJ; Wu SL; Shan ZX; Li XH; Zhou ZL; Lin QX; Liu XY; Yang M; Lin SG; Yu XY
Clin Exp Pharmacol Physiol; 2011 May; 38(5):323-7. PubMed ID: 21388437
[TBL] [Abstract][Full Text] [Related]
9. Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium.
Szentadrassy N; Banyasz T; Biro T; Szabo G; Toth BI; Magyar J; Lazar J; Varro A; Kovacs L; Nanasi PP
Cardiovasc Res; 2005 Mar; 65(4):851-60. PubMed ID: 15721865
[TBL] [Abstract][Full Text] [Related]
10. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both.
Caballero R; de la Fuente MG; Gómez R; Barana A; Amorós I; Dolz-Gaitón P; Osuna L; Almendral J; Atienza F; Fernández-Avilés F; Pita A; Rodríguez-Roda J; Pinto A; Tamargo J; Delpón E
J Am Coll Cardiol; 2010 May; 55(21):2346-54. PubMed ID: 20488306
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin reduces Isus and Ito currents in human atrial myocytes with minor repercussions on action potential duration.
Gluais P; Bastide M; Grandmougin D; Fayad G; Adamantidis M
Fundam Clin Pharmacol; 2003 Dec; 17(6):691-701. PubMed ID: 15015714
[TBL] [Abstract][Full Text] [Related]
12. Effects of ropivacaine on action potential configuration and ion currents in isolated canine ventricular cardiomyocytes.
Szabó A; Szentandrássy N; Birinyi P; Horváth B; Szabó G; Bányász T; Márton I; Magyar J; Nánási PP
Anesthesiology; 2008 Apr; 108(4):693-702. PubMed ID: 18362602
[TBL] [Abstract][Full Text] [Related]
13. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs.
Li GR; Wang HB; Qin GW; Jin MW; Tang Q; Sun HY; Du XL; Deng XL; Zhang XH; Chen JB; Chen L; Xu XH; Cheng LC; Chiu SW; Tse HF; Vanhoutte PM; Lau CP
Circulation; 2008 May; 117(19):2449-57. PubMed ID: 18458165
[TBL] [Abstract][Full Text] [Related]
14. Contribution of I Kr and I K1 to ventricular repolarization in canine and human myocytes: is there any influence of action potential duration?
Jost N; Acsai K; Horváth B; Bányász T; Baczkó I; Bitay M; Bogáts G; Nánási PP
Basic Res Cardiol; 2009 Jan; 104(1):33-41. PubMed ID: 18604626
[TBL] [Abstract][Full Text] [Related]
15. Azimilide inhibits multiple cardiac potassium currents in human atrial myocytes.
Chen F; Esmailian F; Sun W; Wetzel GT; Sarma JS; Singh BN; Klitzner TS
J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):255-64. PubMed ID: 12490972
[TBL] [Abstract][Full Text] [Related]
16. A New Class III Antiarrhythmic Drug Niferidil Prolongs Action Potentials in Guinea Pig Atrial Myocardium via Inhibition of Rapid Delayed Rectifier.
Abramochkin DV; Kuzmin VS; Rosenshtraukh LV
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):525-533. PubMed ID: 29181609
[TBL] [Abstract][Full Text] [Related]
17. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents.
Choe H; Lee YK; Lee YT; Choe H; Ko SH; Joo CU; Kim MH; Kim GS; Eun JS; Kim JH; Chae SW; Kwak YG
J Pharmacol Exp Ther; 2003 Feb; 304(2):706-12. PubMed ID: 12538825
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine inhibits potassium channels in human atrial myocytes.
Cai BZ; Gong DM; Liu Y; Pan ZW; Xu CQ; Bai YL; Qiao GF; Lu YJ; Yang BF
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):851-5. PubMed ID: 17645628
[TBL] [Abstract][Full Text] [Related]
19. Action potential clamp fingerprints of K+ currents in canine cardiomyocytes: their role in ventricular repolarization.
Bányász T; Magyar J; Szentandrássy N; Horváth B; Birinyi P; Szentmiklósi J; Nánási PP
Acta Physiol (Oxf); 2007 Jul; 190(3):189-98. PubMed ID: 17394574
[TBL] [Abstract][Full Text] [Related]
20. Effects of diltiazem and nifedipine on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.
Gao Z; Sun H; Chiu SW; Lau CP; Li GR
Br J Pharmacol; 2005 Feb; 144(4):595-604. PubMed ID: 15678082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
